Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
10/2002
10/03/2002CA2437287A1 Modified granulocyte colony stimulating factor (g-csf) with reduced immunogenicity
10/03/2002CA2437203A1 Vegetative growth-specific promoter and genetically modified plants obtained thereby
10/03/2002CA2436922A1 Rice-origin high expression polypeptide chain elongation factor promoter and method of using the same
10/03/2002CA2436340A1 Histidine-rich glycoprotein
10/03/2002CA2436224A1 Cytotoxic factors for modulating cell death
10/03/2002CA2436208A1 A novel virus (cryptovirus) within the rubulavirus genus and uses therefor
10/03/2002CA2435894A1 End group activated polymers with oligonucleotide ligands
10/03/2002CA2425862A1 Cd19-specific redirected immune cells
10/03/2002CA2406527A1 Novel human stras-like protein and nucleic acids encoding the same
10/02/2002EP1246114A2 Methods for genomic analysis
10/02/2002EP1245681A2 A method for the production of pharmaceutically active recombinant proteins comprising the use of alkanoic acids, their derivatives or salts thereof
10/02/2002EP1245680A1 Gibberellin 2 beta-hydroxylase genes of rice and uses thereof
10/02/2002EP1245678A2 Recombinant proteins of viruses associated with lymphadenopathy syndrome and/or acquired immune deficiency syndrome
10/02/2002EP1245677A1 Nucleic acids and proteins of the mycoplasma hyopneumoniae mhp3 gene and uses thereof
10/02/2002EP1245676A1 Human monoclonal antibodies against tgf-beta ii receptor and medicinal use thereof
10/02/2002EP1245675A1 Cancer cell-specific HLA-F antigen and a diagnostic method of cancer by using thereof
10/02/2002EP1245674A2 Nucleic acid purification
10/02/2002EP1245673A2 Efficient genetic suppressor elements
10/02/2002EP1245672A1 Method of screening candidate for artificial promoter
10/02/2002EP1245669A1 Chamber for the treatment of cells contained in a suspension with an electric field
10/02/2002EP1245574A1 14691, A human glutamate receptor family member and uses therefor
10/02/2002EP1245286A2 Reaction tube and method of use to minimize contamination
10/02/2002EP1245272A1 Substrates, preparation and use
10/02/2002EP1245149A1 Plastid transformation of lycopersicon plants
10/02/2002EP1244916A1 INHIBITION OF $g(b)ARRESTIN MEDIATED EFFECTS PROLONGS AND POTENTIATES OPIOID RECEPTOR-MEDIATED ANALGESIA
10/02/2002EP1244912A2 Methods for screening or evaluating the performance of a set of biological agents in living target cells and their uses
10/02/2002EP1244815A2 Method of analyzing a nucleic acid
10/02/2002EP1244813A2 Amplification based polymorphism detection
10/02/2002EP1244808A1 Method of screening multiply transformed cells using bicistronic expression of fluorescent proteins
10/02/2002EP1244807A1 Il-6 like polynucleotide
10/02/2002EP1244806A2 Reca / rad51 recombinase-mediated production of recombinant organisms
10/02/2002EP1244805A1 Viral core protein-cationic lipid-nucleic acid-delivery complexes
10/02/2002EP1244804A1 Inhibition of cellular proteases
10/02/2002EP1244802A2 Root-specific promoter
10/02/2002EP1244801A2 Modified dhps genes
10/02/2002EP1244800A1 Rapamycin analogs
10/02/2002EP1244799A1 Methods and materials relating to gene expression
10/02/2002EP1244798A2 Vectors capable of immortalizing non-dividing cells and cells immortalized with said vectors
10/02/2002EP1244797A1 Fusion protein delivery system and uses thereof
10/02/2002EP1244796A2 Transduction of recombinases for inducible gene targeting
10/02/2002EP1244795A1 Novel human proteases and polynucleotides encoding the same
10/02/2002EP1244794A1 Mutant apre promoter
10/02/2002EP1244793A2 Serine/threonine kinase and serine protease polypeptides and nucleic acids encoding same
10/02/2002EP1244792A1 Method for obtaining plants enriched in cysteine and glutathione content
10/02/2002EP1244791A2 Method for producing 6-0-alpha-d-glucopyranosyl-d-sorbite
10/02/2002EP1244790A2 Nucleic acids encoding polypeptides having chips activity
10/02/2002EP1244789A2 Genes identified as required for proliferation of e. coli
10/02/2002EP1244788A2 Mutm orthologue and uses thereof
10/02/2002EP1244787A2 Activators of caspases
10/02/2002EP1244786A1 Screening method for compounds capable of modularing egr-1-regulated expression
10/02/2002EP1244785A1 Mus101 and homologues thereof
10/02/2002EP1244784A2 Methods and compositions for inhibiting neoplastic cell growth
10/02/2002EP1244783A1 Improving stability of flint through o-linked glycosylation
10/02/2002EP1244781A2 Antisense oligonucleotides
10/02/2002EP1244780A2 Dna encoding the human serine protease t
10/02/2002EP1244778A2 Human heparanase-related polypeptide and nucleic acid
10/02/2002EP1244776A2 Tetrahydropyrimidine oxygenase gene, polypeptides encoded by said gene and method for producing the same
10/02/2002EP1244775A1 Molecular display on multimeric protein scaffolds derived from the e2 component of the alpha-ketoacid dehydrogenase
10/02/2002EP1244774A2 Pak5 a member of the p21-activated kinase (pak) protein family, nucleic acids and methods related to the same
10/02/2002EP1244773A1 Mutated hepatitis b virus, its nucleic and protein constituents and uses thereof
10/02/2002EP1244772A2 Pathologically modified myocardial cell, production and use thereof
10/02/2002EP1244708A1 Method for treating inflammation
10/02/2002EP1244705A2 Serpentine transmembrane antigens expressed in human prostate cancers and uses thereof
10/02/2002EP1244703A1 Novel abcb9 transporter and uses thereof
10/02/2002EP1244701A1 Transferrin polynucleotides, polypeptides, and antibodies
10/02/2002EP1244700A2 Vesicle trafficking proteins
10/02/2002EP1244698A2 Novel human transporter proteins and polynucleotides encoding the same
10/02/2002EP1244697A2 Novel polypeptides and nucleic acids encoding same
10/02/2002EP1244696A2 Moss genes from physcomitrella patens encoding proteins involved in the synthesis of tocopherols, carotenoids and aromatic amino acids
10/02/2002EP1244695A2 Extracellular matrix and cell adhesion proteins as well as genes encoding them
10/02/2002EP1244694A2 Putative human g-protein coupled receptors
10/02/2002EP1244692A2 Compositions and methods for detecting stress-inducible proteins
10/02/2002EP1244689A2 Cytokine polypeptides and nucleic acids
10/02/2002EP1244686A1 Transforming growth factor alpha hiii
10/02/2002EP1244685A1 Four disulfide core domain-containing (fdcd) polynucleotides, polypeptides, and antibodies
10/02/2002EP1244684A1 Cryptosporidium sporozoite antigens
10/02/2002EP1244683A1 21 human secreted proteins
10/02/2002EP1244667A2 Cyclohexene nucleic acids
10/02/2002EP1244651A1 Diamidine compounds as dna minor groove binders
10/02/2002EP1244630A1 Amphiphilic polyamines, the use and method for synthesis thereof
10/02/2002EP1244466A2 Activation and inhibition of the immune system
10/02/2002EP1244433A2 Inhibitors of the inositol polyphosphate 5-phosphatase ship2 molecule
10/02/2002EP1244360A2 Synergistic insect control
10/02/2002EP1244352A2 Oocyte vitrification technique
10/02/2002EP1244351A1 Animal models for neurodegenerative disease
10/02/2002EP1244349A2 Pyrophosphatase stress-related proteins and methods of use in plants
10/02/2002EP1244348A1 Hybrid winter oilseed rape and methods for producing same
10/02/2002EP1131471B1 A system for cell-based screening
10/02/2002EP1077068B9 Utilization of interferon alpha 5 in the treatment of viral hepatopathies
10/02/2002EP0920538A4 Methods for diagnosing and assessing a predisposition to bipolar affective disorder
10/02/2002EP0915832B1 Boronic compound complexing reagents and highly stable complexes
10/02/2002EP0871778A4 Improved circular site-directed mutagenesis
10/02/2002EP0804448B1 Method for the purification of short nucleic acids
10/02/2002EP0793503B1 Use of the hepatocyte growth factor to induce proliferation and differentiation of hemopoietic cells
10/02/2002EP0792281B1 Process for purification of factor viii
10/02/2002EP0717750B1 Double-stranded peptide nucleic acids
10/02/2002EP0668933B1 Use of methioninase as an antitumor agent in anti-methionine chemotherapy
10/02/2002EP0600930B1 Diagnosis and treatment of autoimmune diseases
10/02/2002DE10151071A1 Nucleic acids stabilized against exonucleases, useful for protein production in cell-free or cellular systems, contains molecules attached to bulky specific binding partners
10/02/2002DE10113815A1 Verfahren zur Isolierung von Plasmiden oder Proteinen aus suspendierten Bakterien- oder Hefezellen Process for the isolation of plasmids or proteins from bacterial or yeast cells suspended
1 ... 2698 2699 2700 2701 2702 2703 2704 2705 2706 2707 2708 2709 2710 2711 2712 2713 2714 2715 2716 2717 2718 ... 4023